Olov Wallner
5Patents
1h-index
12Co-inventors
40Inventor score
Filing activity: Jun 4, 2015 → Mar 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10064869B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 2 | Active |
| US10632125B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10179790B2 | MTH1 inhibitors for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11970474B2 | Substituted benzodiazoles and use thereof in therapy | Human Necessities | 0 | Active |
| US12338226B2 | Substituted benzodiazoles and use thereof in therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.